Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mechanism of Tongxieyaofang in IBS-D
NCT04122586Unknown
- Sponsor
- Xiyuan Hospital
- Start
- Aug 2018
- Primary completion
- Dec 2020
- Modality
- Implantable Devices, Transdermal Patches, Inhalation Devices
- Countries
- 1
01
Overview
Open-label trial of tongxieyaofang in irritable bowel syndrome (IBS) (2 arms), sponsored by Xiyuan Hospital. Primary endpoints: Irritable Bowel Syndrome Symptom Severity Scale at 4 weeks and Bristol Stool Form Scale at 4 weeks. Status: unknown.
02
Drugs
tongxieyaofang
03
Conditions
irritable bowel syndrome (IBS)
Beyond the preview
Go deeper on NCT04122586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04122586.